Sarepta Therapeutics Income Statement - Quarterly (NASDAQ:SRPT)

Add to My Stocks
$36.13 $1.7 (4.49%) SRPT stock closing price Jan 17, 2017 (Closing)

SRPT stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Sarepta Therapeutics stock price. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. Investors typically check YoY or QoQ revenue growth. The operating expenses (also check: Sarepta Therapeutics assets and Sarepta Therapeutics free cash flow) as shown in the Sarepta Therapeutics profit and loss statement 2016-Q3 total to $56.52M. View details of revenue and profits for Sarepta Therapeutics for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Sarepta Therapeutics Net Sales or Revenues
---1.25M---0.03M1.06M2.58M
Cost Of Goods Sold (COGS)----------
Sarepta Therapeutics Gross Profit
---1.25M---0.04M1.05M2.58M
Research & Development Expense34.34M-38.82M41.38M36.67M29.18M39.16M30.84M21.85M20.64M
Selling General & Admin Expense22.18M-20.87M24.34M15.09M12.92M22.69M13.92M12.88M12.21M
Income Before Depreciation Depletion Amortization-56.53M--59.7M-64.46M-51.76M-42.1M-61.86M-44.72M-33.67M-30.27M
Depreciation Depletion Amortization----------
Non Operating Income-0.2M--0.06M-0.23M-0.17M0.25M0.3M0.31M4.44M-3.6M
Interest Expense----------
Sarepta Therapeutics Pretax Income
-56.74M--59.77M-64.7M-51.93M-41.85M-61.55M-44.42M-29.22M-33.87M
Provision for Income Taxes----------
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-56.74M-62.3M-59.77M-64.68M-51.94M-41.85M-61.56M-44.42M-29.23M-33.87M
Extraordinary Items & Discontinued Operations----------
Sarepta Therapeutics Net Income (Profit/Loss)
-56.74M-62.3M-59.77M-64.68M-51.94M-41.85M-61.56M-44.42M-29.23M-33.87M
Average Shares used to compute Diluted EPS48.25M46.16M45.7M44.88M41.57M41.36M41.32M41.3M41.07M39.86M
Average Shares used to compute Basic EPS48.25M46.16M45.7M44.88M41.57M41.36M41.32M41.3M41.07M39.86M
Income Before Nonrecurring Items-52.8M-61.68M-59.77M-64.68M-51.94M-41.85M-61.56M-44.41M-33.48M-33.87M
Income from Nonrecurring Items-3.94M-0.63M------4.26M-
Sarepta Therapeutics Earnings Per Share Basic Net
-1.18-1.35-1.31-1.44-1.25-1.01-1.49-1.08-0.71-0.85
Sarepta Therapeutics Earnings Per Share Diluted Net
-1.18-1.35-1.31-1.44-1.25-1.01-1.49-1.08-0.71-0.85
EPS Diluted Before Nonrecurring Items-1.10-1.34-1.31-1.44-1.25-1.01-1.49-1.08-0.81-0.85
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

1:11
SRPT
The key things to look for in an income statement while doing Sarepta Therapeutics stock analysis are:
  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. Investors look for stocks with a growing top line. An improving bottomline implies that the company is growing profits.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Sarepta Therapeutics historical stock prices to check how the price has moved with time. .